Skip to main content

Table 1 Specific symptoms in women with malignant or benign ovarian tumors and controls (healthy women)

From: Symptoms, CA125 and HE4 for the preoperative prediction of ovarian malignancy in Brazilian women with ovarian masses

 

Malignant

Benign

Controls

p-value

p-value

p-value

 

tumors

tumors

    

(n = 60)

(n = 116)

(150)

(Malignant vs. benign)

(Malignant vs. controls)

(Benign vs. controls)

Symptom

N

(%)

n

(%)

n

(%)

   

Pelvic pain

30

(50.0)

23

(19.7)

2

(1.3)

<0.01

<0.01

<0.01

Abdominal pain

23

(38.3)

10

(8.5)

0

-

<0.01

<0.01

<0.01

Back pain

17

(28.3)

10

(8.6)

0

-

<0.01

<0.01

<0.01

Unable to eat normally

22

(36.7)

8

(6.8)

1

(0.7)

<0.01

<0.01

0.01

Feeling full quickly

22

(36.1)

11

(9.4)

1

(0.7)

<0.01

<0.01

<0.01

Indigestion

15

(24.6)

7

(6.0)

1

(0.7)

<0.01

<0.01

0.02

Nausea or vomiting

11

(18.0)

4

(3.4)

1

(0.7)

<0.01

<0.01

0.17

Weight loss

19

(31.7)

25

(21.6)

11

(7.3)

0.19

<0.01

<0.01

Abdominal bloating

36

(60.0)

32

(27.4)

0

-

<0.01

<0.01

<0.01

Increased abdomen size

38

(63.3)

31

(26.7)

1

(0.7)

<0.01

<0.01

<0.01

Able to feel abdominal mass

14

(23.3)

11

(9.4)

0

-

0.02

<0.01

<0.01

Urinary urgency

8

(13.3)

8

(6.8)

2

(1.3)

0.25

<0.01

0.02

Frequent urination

12

(20.0)

16

(13.7)

2

(1.3)

0.38

<0.01

<0.01

Constipation

2

(3.3)

2

(1.7)

0

-

0.60

0.08

0.18

Diarrhea

3

(5.1)

1

(0.9)

0

-

0.11

0.02

0.43

Menstrual irregularities*

1

(1.6)

1

(0.9)

1

(0.7)

1.0

0.49

1.0

Bleeding after menopause**

6

(10.0)

1

(0.9)

0

-

<0.01

<0.01

0.43

Pain during intercourse***

0

-

0

-

1

(0.7)

NC

1.0

1.0

Bleeding with intercourse

0

-

0

-

0

-

NC

NC

NC

Fatigue

20

(33.3)

16

(13.7)

3

(2.0)

<0.01

<0.01

<0.01

Leg swelling

6

(10.0)

11

(9.4)

1

(0.7)

1.0

<0.01

<0.01

Difficulty breathing

9

(15.0)

5

(4.3)

2

(1.3)

0.02

<0.01

0.24

  1. *only for premenopausal women; **only for postmenopausal women; ***only for sexually active women; NC non-computable.
  2. P-value: bivariate pairwise comparisons using chi-squares or the Fisher’s exact test where appropriate.